China NMPA Drug Inspection - Shanxi Qianyuan Pharmaceutical Group Co., Ltd. - Ginkgo leaf medicine
China NMPA drug inspection for Shanxi Qianyuan Pharmaceutical Group Co., Ltd. published October 15, 2015. Drug: Ginkgo leaf medicine. The State Food and Drug Administration (SFDA) conducted a special supervision and sampling inspection of Ginkgo biloba-b
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanxi Qianyuan Pharmaceutical Group Co., Ltd. published October 15, 2015. Drug: Ginkgo leaf medicine. The State Food and Drug Administration (SFDA) conducted a special supervision and sampling inspection of Ginkgo biloba-b
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox